J. Randall Hoggle obtained undergraduate, doctoral and post-doctoral degrees at Presbyterian College, University of South Carolina, Duke University and the University of Oklahoma, respectively.  He currently serves as Charmain of the Board or Operating Committee for VAI, PSAS and Advasur.  Dr. Hoggle has been a leader in the pharmaceutical and medical device industries, working in a wide spectrum of roles, including business development, business turnaround, strategic partnership development, registration and commercialization.

 

His prior relations (2001-2017) have included founding CEO and Chairman of Health Pathways, Inc. which coordinated FDA submission processes.  From 1999-2001, Dr. Hoggle was CEO and MedContrax, Inc. and its predecessor, which developed the first commercialized contract processing network to synchronize contract information among pharmaceutical manufacturers and group purchasing organizations.  His prior professional relation-ships have included roles at Capital Returns (a private equity firm acquired by FedEx), a turnaround role in the Boehringer Mannheim’s sale of its worldwide operations being sold to Roche Pharmaceuticals, Vice President of Marketing and Sales of Boehringer Mannheim and Director of Corporate Affairs at Eli Lilly and company.